Year-on-year declines in sales and earnings
First written in FY2016-Q2. 19 of 35 entries say "Restated". Latest entry: FY2025-H1.
The whole theme swung hardest in 2020: 29 of 142 companies on the "Worse" side.
3 other companies' latest entry also says "Restated".
- FY2025-H1RestatedAnnual report
「Revenue for the six months ended the second quarter increased across all business segments to ¥1,180,766 million, up 6.5% year on year.」
Revenue increased across all business segments, rising 6.5% year on year. Business profit, operating profit and profit for the interim period attributable to owners of the parent also increased. - FY2024ReframedAnnual report
「Revenue was ¥2,329,861 million, up 15.4% year on year; business profit before R&D investment was ¥744,696 million, up 20.0%; business profit was ¥430,463 million, up 37.7%; and operating profit was ¥323,564 million, up 131.8%.」
From fiscal 2023, when revenue increased across all businesses but operating profit declined, performance changed in fiscal 2024 to substantial increases in revenue, business profit, operating profit and profit attributable to owners of the parent. - FY2024-H1ReframedAnnual report
「Revenue for the six months ended the second quarter increased in the healthcare-related and nutraceuticals-related businesses to ¥1,108,930 million, up 17.0% year on year.」
Consolidated revenue increased 17.0% and business profit increased 37.8%, driven by higher revenue from the healthcare-related and nutraceuticals-related businesses, while operating profit declined 3.4% due to ¥103,293 million in impairment losses related to AVP-786, resulting in higher revenue and business profit but lower operating profit. - FY2024-Q1RestatedAnnual report
「Revenue for the first quarter increased in the healthcare-related and nutraceuticals-related businesses to ¥519,517 million, up 15.9% year on year.」
Driven by higher revenue from the healthcare-related and nutraceuticals-related businesses, consolidated revenue increased 15.9% year on year. Business profit, operating profit and profit for the quarter attributable to owners of the parent also increased. - FY2023ReframedAnnual report
「In fiscal 2023, revenue increased across all business segments to ¥2,018,568 million, up 16.1% year on year. Operating profit was ¥139,612 million, down 7.1%.」
Although revenue increased across all business segments, operating profit declined due to impairment losses related to AVP-786, Deya Foods and products partnered with Sumitomo Pharma Co.,Ltd., resulting in a shift to higher revenue and lower profit. - FY2023-Q3RestatedAnnual report
「Revenue for the nine months ended the third quarter increased across all business segments to ¥1,479,080 million, up 16.8% year on year.」
Revenue increased across all business segments, with consolidated revenue up 16.8% year on year. Business profit was also ¥258,483 million, up 105.6%. - FY2023-Q2RestatedAnnual report
「Revenue for the six months ended the second quarter increased across all business segments to ¥947,537 million, up 16.4% year on year.」
Revenue increased across all business segments, rising 16.4% year on year. Business profit also increased 98.5% year on year, continuing the trend of higher revenue and profit. - FY2023-Q1ReframedAnnual report
「Revenue for the first quarter increased across all businesses to ¥448,344 million, up 17.9% year on year.」
From the previous corresponding quarter, when higher revenue and lower profit coexisted, performance changed in the current first quarter to higher revenue across all businesses and higher profit, with business profit of ¥73,681 million and profit for the quarter attributable to owners of the parent of ¥61,430 million. - FY2022ReframedAnnual report
「Revenue for the fiscal year increased 16.0% year on year to ¥1,737,998 million and grew even excluding the impact of foreign exchange. As a result of higher-than-expected revenue growth and appropriate control of selling, general and administrative expenses, business profit increased 11.3% year on year to ¥174,917 million. Operating profit, however, declined 2.7% to ¥150,323 million.」
Revenue, business profit and profit attributable to owners of the parent increased, while operating profit declined due to the impact of ¥41,521 million in impairment losses, resulting in higher revenue alongside lower operating-level profit. - FY2022-Q3RestatedAnnual report
「Consolidated revenue for the nine months ended the third quarter increased 14.3% year on year to ¥1,266,119 million and grew even excluding the impact of foreign exchange.」
While revenue increased, business profit was ¥125,694 million, down 19.4% year on year, and operating profit was ¥114,848 million, down 27.4%, continuing the trend of higher revenue and lower profit. - FY2022-Q2ReframedAnnual report
「Consolidated revenue increased 13.3% year on year to ¥814,307 million and grew substantially even excluding the impact of foreign exchange.」
Revenue increased 13.3% year on year, while business profit declined 25.1% and operating profit declined 39.6%, resulting in higher revenue alongside lower profit. - FY2022-Q1ReframedAnnual report
「Consolidated revenue increased 12.9% year on year to ¥380,308 million.」
Revenue increased 12.9% year on year, while business profit declined 13.2%, operating profit declined 58.6% and profit for the quarter attributable to owners of the parent declined 48.0%, indicating a shift to performance combining higher revenue and lower profit. - FY2021RestatedAnnual report
「During the fiscal year, the substantial revenue declines caused by the expiration of the contracts for Sprycel and Keppra were more than offset by increased revenue from the four global products Abilify Maintena, Rexulti, Evrysdi and Lonsurf, as well as the nutraceuticals-related business and other operations. Consolidated revenue increased 5.3% year on year to ¥1,498,276 million.」
Although contract expirations caused revenue declines, higher revenue from the four global products and the nutraceuticals-related business and other operations increased full-year consolidated revenue. Operating profit and profit attributable to owners of the parent declined, resulting in higher revenue alongside lower profit. - FY2021-Q3RestatedAnnual report
「During the nine months ended the third quarter, the substantial revenue declines caused by the expiration of the contracts for Sprycel and Keppra were more than offset by increased revenue from the four global products Abilify Maintena, Rexulti, Evrysdi and Lonsurf, as well as the nutraceuticals-related business and other operations. Consolidated revenue increased 3.8% year on year to ¥1,107,417 million.」
Although contract expirations caused revenue declines, higher revenue from the four global products and the nutraceuticals-related business and other operations lifted consolidated revenue 3.8% year on year. Business profit declined 17.4% and operating profit declined 7.9%. - FY2021-Q2ReframedAnnual report
「Consolidated revenue increased 3.4% year on year to ¥718,815 million.」
In the cumulative second quarter, revenue increased 3.4%, while business profit declined 8.5% and operating profit declined 5.8%. Performance reflected higher revenue alongside lower operating-level profit. - FY2021-Q1ReframedAnnual report
「Consolidated revenue was ¥336,789 million, down 0.8% year on year, essentially unchanged from the previous corresponding quarter.」
Revenue declined 0.8% year on year, business profit declined 3.1% and operating profit declined 7.1%, while profit for the quarter increased 18.7% and profit for the quarter attributable to owners of the parent increased 18.5%. Performance changed to a combination of declines at the revenue and operating levels and higher bottom-line profit. - FY2020RestatedAnnual report
「Consolidated revenue increased 1.9% year on year to ¥1,422,826 million.」
Revenue increased 1.9% year on year, operating profit increased 12.5% and profit for the year attributable to owners of the parent increased 16.5%, indicating higher revenue and profit. - FY2020-Q3RestatedAnnual report
「Although the Group's business activities were affected to some extent by the spread of COVID-19 during the nine months ended the third quarter, consolidated revenue increased 3.7% year on year to ¥1,066,959 million.」
In the cumulative third quarter, revenue increased 3.7%, operating profit 10.2%, profit for the quarter 13.7% and profit for the quarter attributable to owners of the parent 14.6%, continuing the trend of higher revenue and profit. - FY2020-Q2RestatedAnnual report
「Consolidated revenue increased 3.6% year on year to ¥695,443 million.」
Revenue increased in the cumulative second quarter, while operating profit, profit for the quarter and profit for the quarter attributable to owners of the parent also increased year on year. - FY2020-Q1ReframedAnnual report
「For the first quarter of the fiscal year, revenue was ¥339,560 million, up 8.2% year on year, operating profit was ¥53,946 million, up 72.9%, profit for the quarter was ¥38,530 million, up 86.1%, and profit for the quarter attributable to owners of the parent was ¥37,710 million, up 96.9%.」
From the mixed performance in the previous first quarter, with higher revenue but lower profit, the current first quarter changed to increases in revenue, operating profit, profit for the quarter and profit attributable to owners of the parent. - FY2019ReframedAnnual report
「The Group reported revenue of ¥1,396,240 million for the fiscal year, up 8.1% year on year, operating profit of ¥176,585 million, up 63.0%, profit for the year of ¥131,187 million, up 53.6%, and profit for the year attributable to owners of the parent of ¥127,151 million, up 54.1%.」
The earnings trend changed from mixed performance in fiscal 2018, with higher revenue and operating profit but lower profit for the year, to increases in revenue, operating profit, profit for the year and profit attributable to owners of the parent in fiscal 2019. - FY2019-Q3RestatedAnnual report
「For the nine months ended the third quarter, revenue was ¥1,028,758 million, up 8.5% year on year, operating profit was ¥155,830 million, up 60.7%, profit for the period was ¥114,892 million, up 42.6%, and profit for the period attributable to owners of the parent was ¥111,519 million, up 42.8%.」
Revenue, operating profit, profit for the quarter and profit attributable to owners of the parent continued to increase year on year. - FY2019-Q2ReframedAnnual report
「For the six months ended the second quarter, revenue was ¥671,131 million, up 8.5% year on year, operating profit was ¥96,524 million, up 22.9%, profit for the period was ¥70,190 million, up 6.6%, and profit for the period attributable to owners of the parent was ¥67,763 million, up 5.4%.」
From the mixed performance in the first quarter, with higher revenue but lower profit, the cumulative second-quarter results changed to increases in revenue, operating profit, profit for the period and profit attributable to owners of the parent, all year on year. - FY2019-Q1RestatedAnnual report
「For the first quarter of the fiscal year, revenue was ¥313,956 million, up 6.6% year on year, operating profit was ¥31,203 million, down 10.3%, profit for the quarter was ¥20,709 million, down 12.0%, and profit for the quarter attributable to owners of the parent was ¥19,152 million, down 15.7%.」
Revenue increased, while operating profit, profit for the quarter and profit attributable to owners of the parent declined year on year, indicating mixed performance. - FY2018ReframedAnnual report
「Against this backdrop, the Group reported revenue of ¥1,291,981 million for the fiscal year, up 4.2% year on year, operating profit of ¥108,304 million, up 4.0%, profit for the year of ¥85,395 million, down 25.3%, and profit for the year attributable to owners of the parent of ¥82,492 million, down 26.7%.」
Revenue and operating profit increased, while profit for the year and profit for the year attributable to owners of the parent declined, resulting in mixed performance. The decline in profit attributable to owners of the parent was primarily due to the reversal of the one-off tax benefit arising from U.S. tax reform in the previous fiscal year. - FY2018-Q3RestatedAnnual report
「For the nine months ended the third quarter, revenue was ¥948,074 million, up 3.2% year on year, operating profit was ¥96,750 million, up 2.0%, profit for the period was ¥80,150 million, up 7.2%, and profit for the period attributable to owners of the parent was ¥77,678 million, up 6.3%.」
Revenue, operating profit, profit for the quarter and profit attributable to owners of the parent continued to increase year on year. - FY2018-Q2RestatedAnnual report
「For the six months ended the second quarter, revenue was ¥618,325 million, up 3.9% year on year, operating profit was ¥78,309 million, up 58.2%, profit for the period was ¥65,389 million, up 50.8%, and profit for the period attributable to owners of the parent was ¥63,876 million, up 50.6%.」
Revenue, operating profit, profit for the quarter and profit attributable to owners of the parent continued to increase year on year. - FY2018-Q1RestatedAnnual report
「For the first quarter of the fiscal year, revenue was ¥294,650 million, up 5.2% year on year, operating profit was ¥34,769 million, up 15.3%, profit for the quarter was ¥23,525 million, up 10.1%, and profit for the quarter attributable to owners of the parent was ¥22,726 million, up 8.2%.」
Revenue, operating profit, profit for the quarter and profit attributable to owners of the parent all continued to increase year on year. - FY2017ReframedAnnual report
「Against this backdrop, the Group reported revenue of ¥1,239,952 million for the fiscal year, up 3.7% year on year, operating profit of ¥104,181 million, up 3.0%, profit for the year of ¥114,387 million, up 22.6%, and profit attributable to owners of the parent of ¥112,492 million, up 21.5%.」
The earnings trend changed from declining or mixed revenue and profit through the previous fiscal year to increases in revenue, operating profit, profit for the year and profit attributable to owners of the parent for the full year. - FY2017-Q3RestatedAnnual report
「For the nine months ended the third quarter of the current fiscal year, sales were ¥919,022 million, up 3.3% year on year. Operating profit was ¥94,885 million, down 25.9%, profit for the quarter was ¥74,784 million, down 31.3%, and profit for the quarter attributable to owners of the parent was ¥73,064 million, down 32.1%.」
The mixed performance continued, with sales increasing year on year while operating profit, profit for the quarter and profit attributable to owners of the parent declined. - FY2017-Q2ReframedAnnual report
「For the six months ended the second quarter of the current fiscal year, sales were ¥595,361 million, up 1.3% year on year. Operating profit was ¥49,506 million, down 39.8%, profit for the quarter was ¥43,368 million, down 13.9%, and profit for the quarter attributable to owners of the parent was ¥42,426 million, down 14.5%.」
Performance has shifted from across-the-board declines in sales and profit to a mixed picture in which sales increased year on year while operating profit and profit declined. - FY2017-Q1RestatedAnnual report
「For the three months ended the first quarter of the current fiscal year, sales were ¥280,192 million, down 0.0% year on year. Operating profit was ¥30,167 million, down 11.2%, profit for the quarter was ¥21,373 million, down 4.3%, and profit for the quarter attributable to owners of the parent was ¥21,012 million, down 3.9%.」
Sales were roughly unchanged from the same quarter of the previous year, while operating profit, profit for the quarter and profit attributable to owners of the parent declined year on year. - FY2016RestatedAnnual report
「For the current consolidated fiscal year, our group's sales were ¥1,195,547 million, down 16.2% from the previous fiscal year. Operating profit was ¥101,145 million, down 32.1%, profit for the period was ¥93,332 million, down 6.1%, and profit for the period attributable to owners of the parent was ¥92,563 million, down 9.2%.」
Full-year sales, operating profit, profit for the period and profit attributable to owners of the parent declined year on year. - FY2016-Q3RestatedAnnual report
「For the nine months ended the third quarter of the current fiscal year, sales were ¥902,797 million, down 18.5% year on year. Operating profit was ¥113,579 million, down 22.8%, ordinary profit was ¥116,128 million, down 25.2%, and profit for the quarter attributable to owners of the parent was ¥90,598 million, down 12.2%.」
Sales, operating profit, ordinary profit and profit for the quarter attributable to owners of the parent for the nine months ended the third quarter declined year on year. - FY2016-Q2First statedAnnual report
「For the six months ended the second quarter of the current fiscal year, sales were ¥594,754 million, down 20.3% year on year. Operating profit was ¥66,170 million, down 35.9%, ordinary profit was ¥65,388 million, down 40.2%, and profit for the quarter attributable to owners of the parent was ¥46,722 million, down 32.7%.」
The main consolidated performance indicators declined year on year.